Gabapentin Capsule
Product Images NDC 82804-206

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 82804-206). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 01)

Chemical structure diagram of the active ingredient Gabapentin, showing its molecular arrangement and functional groups as part of FDA drug labeling.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 02)

A line graph showing mean pain score over an 8-week period, comparing placebo and Gabapentin at 3600 mg/day. The x-axis represents weeks with a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores ranging from 0 to 10. Gabapentin shows a decreasing trend in pain score, while the placebo remains relatively stable.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 03)

A line graph depicting mean pain score over a span of 7 weeks, with groups for placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period, showing changes in pain scores from baseline across time.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 04)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing the percentage of responders between placebo (PBO) and Gabapentin (GBP) at different doses across two studies. Study 1 shows 12% PBO and 29% GBP 3600 mg responders. Study 2 shows 14% PBO, 32% GBP 1800 mg, and 34% GBP 2400 mg responders. Statistical significance is noted with p-values <0.01 and <0.001.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 05)

A scatter plot comparing three studies labeled as study a, study b, and study c, showing percent difference on the y-axis against daily dose in mg on the x-axis. Data points are marked for doses at approximately 600, 900, 1200, and 1800 mg.*

FDA Label Image

82804-206-90 (Image 01)

Label for Gabapentin 300 mg capsules by Proficient Rx LP. The label indicates a package of 90 capsules, each containing 300 mg of Gabapentin, USP. Capsules are described as size '1' hard gelatin with yellow opaque cap and body, imprinted with '300 mg' in blue ink on the cap and '235' in blue ink on the body, filled with white to off-white powder. Manufactured by Graviti Pharmaceuticals Pvt. Ltd., Telangana, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.